Purus Lumina — Device Care & Patient Education

The Patient

This page exists because the clinical pathway did not.

This is a Purus Lumina infrastructure document. It has been submitted to the MHRA, NHS England, the Home Office, NICE, and parliamentary bodies as a formal educational contribution to a documented gap in the UK prescribed medicine pathway. It is published in perpetuity and will not be removed.

---

I — The Patient Position

Prescribed botanical medicine in the United Kingdom is prescribed by a specialist clinician. The device used to consume it is sourced separately by the patient — at their own cost, from wherever they can find it. That distinction is not administrative. It has clinical consequences.

The device sits outside the clinical pathway. No prescriber checks it. No clinic maintains it. No guidance exists for how it should be cleaned, stored, or replaced. The patient is left to manage a medical delivery instrument without a documented standard of care.

Patients are also funding their own treatment in full — consultation fees, prescription costs, device purchase, replacement parts, and repeat prescriptions. Thousands of pounds each year, for a medicine the NHS does not reimburse and a device no institution has formally documented how to maintain.

This curriculum and this page exist because that standard was absent. They document what should have been in place from the outset.

---

II — What Patients May Not Have Been Told

There are things every patient prescribed a dry herb device in the United Kingdom may benefit from knowing. Some of these may not have been raised through the clinical pathway. They are documented here as part of the formal educational record.

Device condition may affect medicine delivery. A contaminated or poorly maintained device may not deliver a prescribed medicine consistently. Residue build-up, degraded components, and incorrect cleaning can all affect what is actually inhaled — and therefore what dose is actually received. The prescription is precise. The condition of the delivery instrument is a variable that has not been formally addressed.

Road use may carry legal considerations. Patients prescribed botanical medicines may wish to seek independent legal advice regarding road use legislation and how it applies to their prescription. A statutory medical defence exists, but the practical implications of exercising it are significant. Patients are encouraged to discuss this with their prescriber and, where appropriate, a solicitor.

Insurance policies may be affected. Standard motor, health, and life insurance policies may be impacted by a CBPM prescription. Patients are encouraged to review their policies and seek independent advice on disclosure obligations. No insurer has produced standardised guidance for patients in this position.

Device warranty considerations. Replacement parts for CE-certified medical devices are available from a range of sources. Patients may wish to confirm that any replacement parts used are genuine manufacturer components, as non-genuine parts may affect device warranty and certified performance.

Off-label use and manufacturer instructions. The MHRA defines off-label use of a medical device as any use that departs from the manufacturer's instructions. Patients may wish to familiarise themselves with the cleaning and maintenance instructions supplied with their device, as these form part of the conditions under which the device is certified for use.

This information is provided as part of a formal educational submission. It is not legal or medical advice. Patients are encouraged to seek independent professional guidance on any of the above.

---

III — The Response

Purus Lumina® was established to address the gap documented above. The company provides the education and the product that should have accompanied the UK prescribed medicine pathway from the outset. This documentation has been submitted to NHS England, the MHRA, the Home Office, NICE, and relevant parliamentary bodies as a formal educational contribution.

---

IV — Patient Experiences on the Record

As part of the formal educational submission to NHS England, the MHRA, the Home Office, and parliamentary bodies, Purus Lumina has documented a pattern of patient experiences that reflect the systemic gap in the UK prescribed medicine pathway. These include:

• Inconsistency between stated and actual prescribed medicine content on prescription packaging
• Patients stopped, tested, or charged under road use legislation while operating within their prescribed limits
• Insurance claims affected or declined following disclosure of a CBPM prescription
• Device issues linked to non-genuine replacement parts
• Clinical interactions in which device care, maintenance, or hygiene was not discussed

If any of the above reflects your experience and you would like it included in the formal record, please contact us. All submissions are treated with complete confidentiality.

---

V — Contact

Device care enquiries are handled directly and in complete confidence by our team. Every enquiry receives a considered response.

We can assist with:

• Device support — guidance on the correct cleaning protocol for your device or help working through the curriculum
• Education guidance — questions about any module, how to apply the protocol to your specific device or prescription, or building a personal care protocol
• Product access — ordering or sizing guidance for the Device Purification Solution

All correspondence is treated with complete confidentiality and will not be shared, published, or referenced without explicit consent.

patients@puruslumina.com

---

Start the Education Programme — Module 1 →

← Return to the Device Care Education hub

Clinics & Wholesale →

---

Patients' Health Is Their Wealth™

Trade mark of Purus Lumina Ltd — application pending.

This page was established on 29 June 2026 and exists in perpetuity as a record of the Purus Lumina commitment to patients prescribed dry herb botanical medicine and the documented gap in the pathway they were placed in. It will not be removed.

Glenn Hailes · Director · Purus Lumina Ltd · 3rd Floor, 86–90 Paul Street · London EC2A 4NE · United Kingdom · Registered in England and Wales